In this context, it is also noteworthy that over-expression of hepcidin in cancer patients contributes to anemia because of the reduced availability of iron for erythropoiesis secondary to the sequestration of iron in cells, mainly in macrophages [46]. The gene discussed is HAMP; the disease is anemia (phenotype).